AGEN
AGEN
NASDAQ · Biotechnology

Agenus Inc

$9.43
+0.89 (+10.42%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +304.3% upside
Low Target $23.34
Average Target $38.13
High Target $40.06
Current Price $9.43
Current
$9.43
Target
$38.13
$23.34 $38.13 avg $40.06
Scenario Analysis
Bear Case
$23.34
147.5%
Low target
Base Case
$38.13
+304.3%
Avg target
Bull Case
$40.06
+324.8%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$8.85
6.6% from high
52-Week Low
$2.71
+248.0% from low
Target vs 52W High
$38.13
+330.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%